logo

For the Inventor, By the Inventor

Hofheim, Germany

Matthias Herrmann

This inventor holds 14 USPTO granted patents and 5 published patent applications and 9 EPO patents. Top assignees: Sanofi, Sanofi-Aventis, Sanofi-A Ventis Deutschland Gmbh. Active years: 2010-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Herrmann. Retrieved from https://idiyas.com/inventor/matthias-herrmann-w28zsrq9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 14.3

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Frankfurt-am-Main, DE (2011 - 2013)
  • Hofheim, DE (2010 - 2015)

Company Filing History:

goldMedal7 out of 1,547 
 
Sanofi
 patents
silverMedal6 out of 390 
 
Sanofi-Aventis
 patents
bronzeMedal1 out of 1,855 
 
Sanofi-A Ventis Deutschland Gmbh
 patents

Years Active: 2010-2015

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 9079906 - Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments (2015-07-14),
2. 8871798 - Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors (2014-10-28),
3. 8853206 - Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments (2014-10-07),
4. 8791133 - Pyridylvinylpyrazoloquinolines as PAR1 inhibitors (2014-07-29),
5. 8598177 - Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments (2013-12-03),
6. 8466169 - [object Object] (2013-06-18),
7. 8329167 - EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases (2012-12-11),
8. 8211427 - EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases (2012-07-03),
9. 8198272 - Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments (2012-06-12),
10. 8114398 - EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease (2012-02-14),
11. 8084198 - Use of a GIP promoter polymorphism (2011-12-27),
12. 8076336 - Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments (2011-12-13),
13. 8071297 - Method for the diagnosis and treatment of cardiovascular diseases (2011-12-06),
14. 7785781 - Method of diagnosis of a predisposition to develop thrombotic disease and its uses (2010-08-31),

Title: Matthias Herrmann - Innovative Inventor from Hofheim

Introduction: Matthias Herrmann is a renowned inventor hailing from Hofheim, Germany, known for his groundbreaking contributions to various industries.

Latest Patents: Matthias Herrmann holds several patents in the fields of renewable energy, sustainable technology, and advanced materials.

Career Highlights: With a career spanning over two decades, Matthias Herrmann has worked on numerous projects that have revolutionized the way we approach environmental challenges and technological advancements.

Collaborations: Throughout his career, Matthias Herrmann has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life and make a positive impact on society.

Conclusion: Matthias Herrmann's dedication to innovation and his passion for creating a sustainable future have solidified his position as a visionary inventor in the global landscape of technology and science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…